{
    "output": {
        "input_text": "PET-CT Whole BodyStaging of known non-small cell lung cancerFindings:\nLung Mass: Hypermetabolic mass in the left upper lobe, SUV max 12.5, consistent with known primary tumor.\nMediastinal Lymph Nodes: Hypermetabolic lymph nodes in the subcarinal region (SUV max 6.8), suggestive of metastatic involvement.\nDistant Metastasis: No hypermetabolic lesions identified in the liver, adrenal glands, bones, or brain to suggest distant metastases.\nBackground Activity: Physiological tracer uptake in other organs.\n\nImpression:\nHypermetabolic primary lung tumor in the left upper lobe.\nSuspicious mediastinal lymph nodes, likely metastatic.\nNo evidence of distant metastatic disease.",
        "keywords": [
            "P",
            "##ET",
            "-",
            "CT Whole Body",
            "##S",
            "##tag",
            "##ing of",
            "known",
            "non -",
            "small cell lung cancer",
            "##Findings : Lung",
            "Mass",
            ": Hyper",
            "##met",
            "##ab",
            "##olic mass",
            "in the left upper lobe",
            ",",
            "SUV ma",
            "##x",
            "12.",
            "5",
            ", consistent with",
            "known",
            "primary tumor. Mediastinal L",
            "##ymph",
            "Nodes : Hyper",
            "##met",
            "##abolic l",
            "##ymph",
            "nodes in the subcarinal region",
            "(",
            "SUV ma",
            "##x",
            "6.",
            "8",
            "), suggestive of metastatic",
            "involvement",
            ". Distant",
            "Metastasis",
            ":",
            "No",
            "hyper",
            "##metabolic",
            "lesions identified in the liver, adrenal glands, bones, or brain to suggest distant metastases.",
            "Background Activity",
            ": Physiological trace",
            "##r",
            "uptake in other organs. I",
            "##mpression",
            ": H",
            "##ypermet",
            "##ab",
            "##olic primary lung tumor",
            "in the left upper lobe.",
            "Suspicious",
            "mediastinal l",
            "##ymph",
            "nodes, likely metastatic. No evidence of distant metastatic disease",
            "."
        ],
        "text": "```json\n{\n  \"terms\": [\n    {\n      \"term\": \"PET-CT\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Positron Emission Tomography-Computed Tomography, a hybrid imaging modality that combines PET and CT scans to provide detailed information about the body's metabolic activity and anatomical structure.\",\n      \"relevance\": \"Used for whole-body staging of known non-small cell lung cancer to assess the extent of disease spread.\",\n      \"relation\": \"Context: Whole-body staging of known non-small cell lung cancer\",\n      \"value\": null\n    },\n    {\n      \"term\": \"Whole Body\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"A comprehensive imaging examination that includes all parts of the body, from head to toe.\",\n      \"relevance\": \"Used for staging of known non-small cell lung cancer to assess disease spread throughout the entire body.\",\n      \"relation\": \"Context: Whole-body staging of known non-small cell lung cancer\",\n      \"value\": null\n    },\n    {\n      \"term\": \"non-small cell lung cancer\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"A type of lung cancer that accounts for the majority of cases, characterized by uncontrolled growth of abnormal cells in the lungs.\",\n      \"relevance\": \"The primary tumor being staged with PET-CT Whole Body imaging.\",\n      \"relation\": \"Context: Known primary tumor and mediastinal lymph node metastasis\",\n      \"value\": null\n    },\n    {\n      \"term\": \"Lung Mass\",\n      \"category\": \"Imaging finding\",\n      \"explanation\": \"A visible lesion or abnormality in the lung tissue, detected through imaging studies.\",\n      \"relevance\": \"Hypermetabolic mass in the left upper lobe, consistent with known primary tumor.\",\n      \"relation\": \"Context: Known primary tumor\",\n      \"value\": null\n    },\n    {\n      \"term\": \"SUV max 12.5\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Standardized uptake value maximum of 12.5, a measure used to quantify the metabolic activity of tissues.\",\n      \"relevance\": \"Indicates high metabolic activity in the lung mass.\",\n      \"relation\": \"Context: Lung Mass and Background Activity\",\n      \"value\": 12.5\n    },\n    {\n      \"term\": \"Mediastinal Lymph Nodes\",\n      \"category\": \"Anatomical structure\",\n      \"explanation\": \"Lymph nodes located in the mediastinum, a region between the lungs.\",\n      \"relevance\": \"Hypermetabolic lymph nodes in the subcarinal region, suggestive of metastatic involvement.\",\n      \"relation\": \"Context: Suspicious mediastinal lymph node involvement\",\n      \"value\": null\n    },\n    {\n      \"term\": \"SUV max 6.8\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Standardized uptake value maximum of 6.8, a measure used to quantify the metabolic activity of tissues.\",\n      \"relevance\": \"Indicates moderate metabolic activity in the mediastinal lymph nodes.\",\n      \"relation\": \"Context: Mediastinal Lymph Nodes and Background Activity\",\n      \"value\": 6.8\n    },\n    {\n      \"term\": \"Distant Metastasis\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"The spread of cancer to distant parts of the body, beyond the primary site.\",\n      \"relevance\": \"No hypermetabolic lesions identified in the liver, adrenal glands, bones, or brain to suggest distant metastases.\",\n      \"relation\": \"Context: No evidence of distant metastatic disease\",\n      \"value\": null\n    },\n    {\n      \"term\": \"Background Activity\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Normal physiological uptake of the PET tracer in various organs, used as a reference for interpreting imaging results.\",\n      \"relevance\": \"Physiological tracer uptake in other organs.\",\n      \"relation\": \"Context: Assessment of normal background activity to interpret abnormal findings\",\n      \"value\": null\n    },\n    {\n      \"term\": \"Hypermetabolic\",\n      \"category\": \"Technical term\",\n      \"explanation\": \"Exhibiting high metabolic activity, as detected by PET imaging.\",\n      \"relevance\": \"Characteristics of the lung mass and mediastinal lymph nodes.\",\n      \"relation\": \"Context: Assessment of tumor biology and aggressiveness\",\n      \"value\": null\n    },\n    {\n      \"term\": \"Metastatic\",\n      \"category\": \"Medical condition\",\n      \"explanation\": \"The spread of cancer from a primary site to other parts of the body, resulting in secondary tumors.\",\n      \"relevance\": \"Involvement of mediastinal lymph nodes and distant organs.\",\n      \"relation\": \"Context: Known primary tumor and distant metastases\",\n      \"value\": null\n    }\n  ]\n}\n```"
    }
}